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Abstract
Background: Antiretroviral treatment (ART) service scaling up has been practiced in the Ethiopia since 2006. Regardless
of increasing number of primary health care centers providing the service, the existing hospitals are still overcrowded
with ART service seeking patients may be because of the common belief that treatment outcome is better for hospital
patients than those treated at the primary health centers. However, documented evidence comparing the treatment
outcome for the two categories of health facilities is scarce in the study setting. The purpose of the current study was to
compare major treatment outcomes among new patients treated at the two health facility categories.
Method: Retrospective cohort study was implemented using secondary data from medical records collected between
October 2010 and January 2014 in the selected health facilities. All patients (1895) who started the treatment in the
facilities during the period were included in the study. Univariate analyses were made using descriptive methods such as
frequency distributions and measures of central tendency. Bivariate and multivariate analyses were made using Kaplan
Meier and Cox regression models respectively to compare the mean survival time between the two facility categories. P-
value less than 0.05 was considered as statistically significant.
Results: A total of 1895 patient records were followed for 27,990 person-months. Risks of unwanted treatment
outcomes (death and lose-to-follow-up) were the same for both categories of patients. The median survival probability
was similar to the facility categories (P-value = 0.11). Baseline performance scale III/IV (AHR, 2.4; 95 % CI: 2.0, 3.0),
baseline WHO clinical stages III/IV (AHR, 2.8; 95 % CI: 2.3, 3.4), and low adherence (<95 %) to ART drugs (AHR, 3.4; 95 %
CI: 2.8, 5.2) were the independent predictors of the unwanted treatment outcomes.
Conclusion: Antiretroviral treatment service delivery at primary health care facilities did not compromise the treatment
outcomes among adult ART naïve patients. This implies that, ART services decentralization can result in acceptable
treatment outcome in less developed settings. Therefore, treatment requiring patients should be encouraged to start
the treatment in either of the health facilities as early as possible.
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Background
Human immunodeficiency virus (HIV) has continued to
be an enormous challenge worldwide. Since its recogni-
tion, HIV has infected close to 70 million people, and
more than 34 million have died due to acquired immuno-
deficiency syndrome (AIDS) [1]. Although there is slight
decline in the burden of the disease, it is still causing chal-
lenges to the world [1, 2]. Globally, there were an esti-
mated 36.9 million people living with HIV, 2.0 million
new HIV infections and 1.2 million deaths due to the dis-
ease in 2014 [3]. In sub Saharan Africa alone, about 25.8
million people were living with HIV and the region
accounted for 70 % of the new infections in the world in
the year [4]. Antiretroviral treatment (ART) scale up is on-
going globally [3]; although 14.9 million (only 40 % of the
patients in need of the treatment) were on ART of which
13.5 million were in low and middle income countries in
2014 [4]. Ethiopia is the second most populous in Africa
[5] and one of the seriously affected countries in sub Sa-
haran Africa [2, 6]. The estimated prevalence of HIV/
AIDS in Ethiopia was 1.5 % with urban and rural estima-
tion of 4.2 and 0.6 %, respectively in the year 2011 [4].
Indeed, the use of ART drugs (the drugs prescribed to
HIV/AIDS patients based on defined criteria) dates back to
about two and half decades in developed countries, while
its use started in 2003 in Ethiopia [7]. In this country, free
ART service was launched to be given in public hospitals in
2005 and in primary health care centers in 2006 as part of
the service scaling-up [8, 9]. The criteria used to start pa-
tients on ART in Ethiopia include WHO clinical staging,
TLC-count and CD4- count as used in combination or sep-
arately [6, 10].
Accordingly, in Ethiopia the number of patients ever
started ART was 439,301, of which 317,443 were on the
treatment since in 2013 [8]. The number of ART provid-
ing facilities is increasing, (reaching 318 in Oromia re-
gion and 913 nationally) of which about 80 % are in
primary health care centers [8, 11].
Comparing the survival of patients treated as relatively
established health facilities and those treated in newly in-
coming primary health care centers can inform both the
practitioners and the program mangers as to what is hap-
pening as ART service scaling up to mid-level health
workers. Nonetheless, evidence showing what was happen-
ing to the survival of the adult patients who were enrolled
into the treatment in hospitals and health centers was
scarce. Therefore, this study compared the survival of adult
patients who were new to ART between a hospital and
health centers.
Methods
Study design, setting and period
A retrospective cohort design was used to analyze data
obtained from medical records of patients on ART in
southern central Oromia regional state. In Ethiopia, the
health service delivery system has three tiers. The first
tier is known as the primary health care unit where non
physician clinicians and other less trained health workers
provide basic and primary health care services. This tier
includes health service delivery facility known as health
center. The other two tiers are general hospitals and spe-
cialized referral hospital where more qualified practi-
tioner provides medical services to the patients.
The two study settings compared in the current study
were primary health care centers (the exposure setting) and
hospitals. In the primary health care centers middle and
low level health workers such as nurses and health officers
(graduates of Bachelor of Science degree in public health)
are responsible for patient care. The centers are out of
major towns and less equipped with health care facilities.
They have newly received the responsibility to provide ART
services as a result of the service decentralization. As a re-
sult of lesser expertise of the health care providers and
lesser health care facility in the primary health care centers,
patients treated at this set up were considered to be ex-
posed group. In the second health care facility, the hospi-
tals, medical doctors are responsible to provide ART
services. Hospitals are located in urban settings and have
better health care facilities as compared to the primary
health care centers. We analyzed and compared the major
ART services outcomes using medical records collected be-
tween October 01, 2010 and January 30, 2014.
Population
Source population for the current study was all new adult
HIV/AIDS patients, who have ever started on highly active
antiretroviral treatment (HAART) regimen in the study
area and other similar areas. All public health facilities
which have been providing ART service since October,
2010 in the study area were selected for the study. Adult
ART naïve patients (15 years or older), treated in the se-
lected health facilities were included in the study. Those
patients recorded as transferred out to other health facil-
ities to follow the treatment elsewhere for the whole dur-
ation since the transfer out were excluded from the study.
Analysis
A total of 1895 medical records (all that meet the inclu-
sion criteria) obtained from the standardized ART regis-
ters, 1307 and 588 from hospital and health center
respectively were analyzed. Using EPI Info computer soft-
ware sample size calculation formulae, and considering
95 % confidence level, 80 % power, unexposed to exposed
group ratio of two and relative risk of two, total sample
size of 900 could be statistically sufficient. We increased
the sample size to more than double to get more reliable
result. Variables with missing data were separately ana-
lyzed and compared for the two categories of the health
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facilities. All data collectors and supervisors were trained
on the tools for consistency and supported by close super-
vision during data collection. EPI-Info version 6 was used
for data entry [12]. The entered data were cleaned through
the phase by phase screening after exporting to the SPSS
statistical computer software version 20 [13]. This was
done, first by sorting variables with incomplete values.
Values missed at entry were completed from the hard
copy of the collected data. Then, we ran separate frequen-
cies for each variable to further check and clean the data.
Descriptive statistical methods were used in univariate
analysis to generate frequencies and measure of central
tendencies. The hypothesis of no survival difference among
ART naïve patients treated in both health facility categories
was also tested. Bivariate and multivariate analyses were
made using Kaplan Meier and Cox regression models re-
spectively, to compare the survival rate among patients of
the two categories. We fit Cox regression model including
all variables reported in Table 3. Survival rate is explained
by the mean survival time of patients before death or lost
to follow up (LTFU). Chi-square test was also used to com-
pare categorized outcomes. If a patient misses the treat-
ment follow up appointment for over a month after the
appointment date and death could not be ascertained, then
the patient was categorized as LTFU. In this study, we
fitted survival model considering two different scenarios.
In the first scenario, we considered the event of death and
LTFU together as event of interest; while in the second
scenario, we considered only confirmed deaths as event of
interest. P-value less than 0.05 was considered as
statistically significant.
Results
The medical records of 1895 ART naïve patients were an-
alyzed. The ratio of hospital patients to that of health cen-
ters was about two to one. More than half of the patients,
1061 (56 %) were females and the median age was 24 years
with an inter quartile range (IQR) of 15.8 to 31.80 years.
Most of the patients, 1376 (70 %) were urban dwellers and
over half of them, 1042 (55 %) were people within marital
union. Only 531 (28 %) of the patients have attended high
school level education or above. Half of the patients, 947
(50 %) were either self-employed or employed by others.
That means, about 50 % of the study participants had cer-
tain monitory income from the work they were engaged
in. House wives and other participants who were not in-
volved in jobs with direct financial gains are considered
jobless in this study (Table 1).
Data completeness rate was high (over 90 %) for all re-
quired variables in the study. From the total study par-
ticipants, 1844 (97 %) had baseline body weight
documented and the median weight was 50 kg with IQR
44 to 56 kg. Number of medical records with missing
variables was compared for the two study settings to
check for significant difference, and there was no differ-
ence in the missing data between the two categories of
the health facilities. We compared the baseline data of
the patients treated in the two facility categories such as
CD4 count, body weight and WHO clinical stages. There
was no difference in the baseline weight between hos-
pital and health center patients (P-value = 0.35) and CD4
count (P-value = 0.31). The total of 1204 patients had ad-
vanced disease stage (WHO clinical state III/IV); of
which 811 (67.4 %) were seen at hospital level.
The incidence rate of death in health center patients was
5.7 per 1000 person-months, while that of hospital patients
was 6.3 per 1000 person-month of observation. The
incidence rate of (LTFU) was 7.9 and 8.6 per 1000 person-
months for health centers and hospital patients, respect-
ively. Using two-by-two table with chi-square test statistics,
we found that there was no statistically significant differ-
ence in incidence of both death and LTFU among patients
Table 1 Socio-demographic characteristics of study participants;
October, 2010 to January, 2014
Variables Frequency Percentages (%)
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treated at the hospital and health centers (P-values of 0.86
and 0.89) respectively. Among the health center patients
with known performance scale, 511 (92.1 %) were improved
from bed ridden or sick ambulatory to working perform-
ance scale; while 992 (76.1 %) of such hospital patients
showed similar improvement. Immunological improvement
(gain in CD4 cells count) was higher among health center
patients than among hospital patients (P-value <0.001).
Considering the worst scenario (death or LTFU as an
event of interest), the Kaplan Meier model was fitted to
test for the difference between the mean survivals of pa-
tients treated in the two categories of the health facilities.
The mean survival time was 31.3 months; (95 % CI: 30.0,
32.6) and 30.3 %; (95 % CI: 29.4, 31.1) months for health
center and hospital patients respectively. The mean sur-
vival time was similar for patients of both health facility
categories (P-value = 0.11) (Table 2).
The survival probability curve was fitted for two extreme
scenarios, the worst where LTFU cases were categorized
with death as an event of interest and the other scenarios
where only death was considered as an event of interest
separately (Figs. 1 and 2). In both cases, although the differ-
ence was not statistically significant as shown in Table 2
above, patients treated at health center had better survival
probability at any time during the follow up period.
There was no statistically significant association between
the type of health facility attended by patients and risk of
death and LTFU (P-value = 0. 11). The risk of death or
LTFU was more than two times higher among patients
who were bed ridden or sick ambulatory at admission
compared to those who had working functional status
with adjusted hazard ratio ((AHR), 2.4; 95 % CI: 2.0, 3.0).
The risk was over three times higher among patients with
advanced disease stage at the start of the treatment as
compared to those who had no advanced disease (AHR,
2.8; 95 % CI: 2.3, 3.4). Risk of the event of interest (death
and LTFU) was higher among male patients (AHR, 1.4; 95
% CI: 1.1, 1.7). There was no statistically significant associ-
ation between the type of health facility attended by pa-
tients and risk of death or LTFU (P-value = 0. 11). Any
adjusted hazard ratio reported for a particular variable in
Table 3 is adjusted for all other variables in the table.
Discussion
The current study showed the persistence of dispropor-
tionately high caseload to hospitals, with 1307 (69 %) were
being treated at hospital. This high case load in hospital
was similar to that of the 2009 Ethiopian national cohort
analysis, which reported that 87.8 % of ART patients were
receiving the treatment from hospitals [14]. The change of
the hospital load from 87.8 to 69 % can be explained by
the fact that ART service scaling up to health centers is
ever increasing in the country [8, 15, 16]. Similar to the
Fig. 1 Survival Probability curve comparing primary health care centre ART patients with those of hospital based on risk of failure (Death and LTFU),
October, 2010 to January, 2014
Table 2 Comparison of mean survival of patients treated in
Hospital versus that of Health center; October, 2010 to
January, 2014
Facility Mean survival (95 % CI) X2 (1) P-Value
Health center 31.3 (30.0,32.6) 2.6 0.11
Hospital 30.3 (29.4,31.3)
Megerso and Garoma BMC Health Services Research  (2016) 16:581 Page 4 of 7
report of the national study done in Ethiopia [14], about
two third of the patients (1428) were in the age range be-
tween 15 and 39 years. This higher proportion of the
younger age may be due to higher disease burden in this
age group [2, 4]. Moreover, the higher proportion of fe-
males patients 1061 (56 %) and urban residents 1376
(70 %) in the current study matches with an HIV preva-
lence trend in the country [4, 16, 17].
In the current study, the median baseline CD4 count
was 130 Cells/ml and 140 Cells/ml for health centers
and hospital patients, respectively. These counts were
higher than the finding of other studies conducted in de-
veloping countries [18, 19]. This higher CD4 count at
the initiation of the treatment could be attributed to the
increasing access to the ART service which is facilitating
for the early initiation of the treatment. We also con-
firmed that there was no difference between end-line
mean counts of CD4 cells for the patients treated in ei-
ther facility; and there was no difference in the treat-
ment outcome for the facilities. The survival probability
for patients of both facilities was similarly higher than
80 % at the fourth month of follow up.
In this study, we also found that being treated at the
health center did not increase risk of death or LTFU to
adult ART naïve patients. This finding was consistent with
similar studies in Africa [18, 20–22]. The current finding
was also similar to the recent Ethiopian national study find-
ing which showed relatively better survival rate of patients
treated in the primary health care centers as compared to
those of hospitals (82 and 72 %, respectively) [23].. This
result was also in agreement with the findings of another
study in South Africa and Cameroon which reported task
shifting for HIV/AIDS care to relatively lower levels of the
health system that did not compromise quality and rather
associated with good ART outcomes [18, 20, 21, 24, 25].
Similarity, between the treatment outcomes in the two
health facility categories could also be due strengthened
mentoring of the service provision at both levels by
trained health workers from outside the facilities. [26].
Strong predictors of death and LTFU were poor baseline
functional status (being bed ridden or sick ambulatory),
advanced disease stage and ART adherence less than 95 %.
This findings were similar to study results from Brazil,
and elsewhere [24, 27, 28] which showed that poor per-
formance scale and WHO stage III/IV [6] as strong pre-
dictors of adult ART patients survival. Initiation and
adherence to CPT was associated with event of interest
and this result is in agreement with the result of the other
study done in Ethiopia [19].
Limitation of the study was the fact that it was facility
based where ascertaining the registered outcomes was
impossible except relying on the ascertainments done
by case managers working in respective health facilities.
That means, registered outcomes such as death and
LTFU were taken from health facility records without
further ascertainment by the research team. But both
categories of the health facilities have ascertainment
mechanisms of the outcomes. The other limitation was
the scope of the study which was confined to sub re-
gion, yet the results can be used in other parts of the
Fig. 2 Survival probability curve comparing Health center and Hospital ART patients based on risk of death; October, 2010 to January, 2014
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region as there were similar ART service implementa-
tion strategies were followed in the whole region.
Conclusion
In conclusion, the antiretroviral treatment outcome among
ART naïve adult patients was not significantly different
among patients treated at the primary health care centers
and from those treated at hospital. The most important
predictors of death and LTFU were having poor base line
performance scale, advanced disease stage at the start of
the treatment and poor adherence to ART regimens.
Therefore, concerted efforts should be made by concerned
bodies to encourage the patients to start the treatment in
either of the health facilities as early as possible.
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